|
gptkb:FGF3_gene
|
genetic testing for hearing loss
|
|
gptkb:troponin
|
troponin I test
|
|
gptkb:Chikungunya_vaccine_(under_development)
|
Phase 3
|
|
gptkb:Ipatasertib
|
Phase III
|
|
gptkb:Z-endoxifen
|
Phase III
|
|
gptkb:ALT-803
|
Phase 2
|
|
gptkb:GB0139
|
Phase 2
|
|
gptkb:HER2_receptor
|
immunohistochemistry
|
|
gptkb:SV-17
|
Phase 1
|
|
gptkb:PRLR
|
prolactin receptor antibody test
|
|
gptkb:CORT118335
|
Phase 3
|
|
gptkb:NCT05149502
|
Phase 1
|
|
gptkb:ONCR-021
|
Phase 1
|
|
gptkb:Targeted_Protein_Degradation
|
gptkb:NCT04072952
|
|
gptkb:MK-0826
|
Phase III (terminated)
|
|
gptkb:otelixizumab
|
Phase III (terminated)
|
|
gptkb:trastuzumab
|
Phase III
|
|
gptkb:Longeveron_Inc.
|
hypoplastic left heart syndrome
|
|
gptkb:obinutuzumab_plus_chlorambucil
|
CLL11 study
|
|
gptkb:ATG-016
|
Phase I/II
|